> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Updated CDER Guidance Agenda
- URL: https://www.fdaweb.com/updated-cder-guidance-agenda/
- Published: 2024-08-01T12:00:00.000Z
- Updated: 2026-09-14T14:37:13.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157482

CDER has posted a revised guidance agenda for calendar year 2024\. The [agenda](https://www.fda.gov/media/134778/download?ref=fdaweb.com) lists 101 new, revised draft, and immediately effective guidances in these 17 categories: Administrative/Procedural (11), Biosimilars (4), Clinical/Antimicrobial (1), Clinical/Medical (20), Clinical Pharmacology (1), Compounding (7), Drug Development Tools (1), Drug Safety (3), Generics (21), International Council on Harmonization (10), Labeling (3), Over-the-Counter Drugs (2), Pharmaceutical Quality CGMP (3), Pharmaceutical Quality/CMC (10), Pharmacology Toxicology (2), Promotional Labeling and Advertising (1), Real-World Data/Real-World Evidence (3).

The document lists 12 guidances that were added since the January posting of the initial guidance agenda.